Abiopharma

Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®

Vaxart to Host Upcoming Conference Calls

Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025

Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M

Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Grifols Communication: Grifols welcomes Fitch Ratings’ outlook revision to positive and affirmation of ‘B+’ Rating

Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program

Zimmer Biomet Holdings, Inc. Notification

Gossamer Bio to Participate in Upcoming Investor Conferences

Organon & Co. - Organon Announces Agreement to Divest itsJADA® System for Up to $465 Million to Laborie